Staff Members - Benha University
Changes of the central macular thickness after phacoemulsification in type 1 and type 2 DM using OCT
• 2015
Publication Information
Authors
A.El Barky (MD, FRCS)
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Purpose:
To measure the central macular thickness changes after phacoemulsification surgery in type 1 and type2 DM and correlate this with the degree of diabetic retinopathy (DR).
Methods:
This study included 60 eyes of diabetic patients (35 eyes of patients with type 1 DM and 25 eyes of patients with type 2 DM).All patients underwent uneventful phacoemulsification. The Central macular thickness was measured using optical coherence tomography preoperatively and at 1 and 3 months postoperatively.
Results:
A significant increase could be detected on the postoperative 1 and 3 months in the central macular thickness in all operated eyes. The initial preoperative average value of central macular thickness in the type 1 and type 2 diabetic patients were 182+/- 54 and 172+/-27 microns, increased to 210+/-49 and 183+/-34 microns at 1month, and to 215+/- 53 and 185+/-31 microns at 3 months after surgery, respectively. The operated eyes subdivided into 2 groups, no DR and DR groups. The mean (±SD) central macular thickness in the no DR and DR groups were 174+/-25 and 185+/- 57 microns, increased to 185+/-31 and 216+/-52 microns 1month, and to188+/-29 and 219+/- 50 microns 3 months after surgery, respectively.
Conclusions:
Diabetes influences significantly the central macular thickness even after uncomplicated phacoemulsification. The increase in macular thickness reached the maximum at 1 month postoperative, associated with diminution of vision, with limited visual improvement at 3 months. These changes were more prominent in type1 DM group than type 2 DM and DR group than no DR group.
To measure the central macular thickness changes after phacoemulsification surgery in type 1 and type2 DM and correlate this with the degree of diabetic retinopathy (DR).
Methods:
This study included 60 eyes of diabetic patients (35 eyes of patients with type 1 DM and 25 eyes of patients with type 2 DM).All patients underwent uneventful phacoemulsification. The Central macular thickness was measured using optical coherence tomography preoperatively and at 1 and 3 months postoperatively.
Results:
A significant increase could be detected on the postoperative 1 and 3 months in the central macular thickness in all operated eyes. The initial preoperative average value of central macular thickness in the type 1 and type 2 diabetic patients were 182+/- 54 and 172+/-27 microns, increased to 210+/-49 and 183+/-34 microns at 1month, and to 215+/- 53 and 185+/-31 microns at 3 months after surgery, respectively. The operated eyes subdivided into 2 groups, no DR and DR groups. The mean (±SD) central macular thickness in the no DR and DR groups were 174+/-25 and 185+/- 57 microns, increased to 185+/-31 and 216+/-52 microns 1month, and to188+/-29 and 219+/- 50 microns 3 months after surgery, respectively.
Conclusions:
Diabetes influences significantly the central macular thickness even after uncomplicated phacoemulsification. The increase in macular thickness reached the maximum at 1 month postoperative, associated with diminution of vision, with limited visual improvement at 3 months. These changes were more prominent in type1 DM group than type 2 DM and DR group than no DR group.